FEB 04, 2021
1-Minute Video; ASPORS 2020
Oculoplastics/Orbit, Thyroid Eye Disease
In this 1-Minute Video, Dr. Julian Perry shares updates on using teprotumumab for chronic thyroid eye disease. He discusses findings from a case series involving 7 patients with postinflammatory TED. Treatment with teprotumumab led to improvement in all 7 patients, suggesting the drug could offer relief for patients who have active or chronic TED.
Relevant Financial Disclosures: None